Sunshine Biopharma Inc is a Colorado corporation founded in 2009 and headquartered in the greater Montreal area, Canada. The company operates in the Biopharma and Biotechnology industries, aiming to make a significant impact in these sectors.
Sunshine Biopharma Inc. is a fully reporting company in the U.S. (www.SEC.gov) and Canada (www.SEDAR.com). Its shares of Common Stock are publicly traded on the NASDAQ market (nasdaq.com) under the ticker symbol SBFM.
The company recently secured a notable $10.00 million Post-IPO Equity investment on 13 February 2024. The investors involved in this funding round are currently unspecified.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $10.00M | - | 13 Feb 2024 | |
| Post-IPO Equity | $8.00M | - | 14 Mar 2022 | |
| Post-IPO Debt | $900.00K | 1 |
|
20 Jul 2021 |
| Post-IPO Equity | $500.00K | 1 |
|
22 Apr 2021 |
| Post-IPO Debt | $2.05M | 1 |
|
23 Mar 2021 |
No recent news or press coverage available for Sunshine Biopharma Inc.
We care about your data, and we'd love to use cookies make your experience better.
